The twelfth workshop in the series "Beyond the Identification of Transcribed Sequences -Functional, Expression and Evolutionary Analysis" was held October [26] [27] [28] 2002 , in Washington DC and was again sponsored by the US Department of Energy. The seventy attendees discussed a broad range of topics relevant to genomics, gene identification, RNA analysis, and post-genome-sequencing questions of functional assessments. Consistent with developments in the field, several topics received increased attention and some new topics were introduced. In functional analyses, large-scale mutagenesis projects in mouse and fish are expanding rapidly, protein chips are verging on practicality and determining network connections and interactions among genes is being approached from multiple avenues. In expression studies, cDNA arrays remain popular but new applications are addressing additional mRNA characteristics, including stability and translation, detection of large scale basal transcription of apparent intergenic and intron sequences creates new questions, and nonsense mediated decay provides potential new insights into functions of alternative splice variants. Evolutionary topics included new estimates of the timing of increased organismal complexity, patterns of genomic and gene duplication in vertebrates, and detection among primates of human-specific sequences. Summaries of oral presentations follow.
Mutation and SNP analysis
Geoffrey Hicks (Manitoba Institute of Cell Biology) discussed the procedure of tagged sequence mutagenesis using retroviral insertions in ES cells. Currently 1 4000 lines with single insertion sites are available, with F 33 % disrupting known genes. It is anticipated that 10,000-20,000 ES cell lines bearing disruptions of specific genes eventually will be available. Data on these genes can be obtained through a web-based database (http://www.Escells.ca). This effort is part of a large international consortium on mouse mutagenesis that offers the promise in the near future of providing an array of mouse mutations with coverage comparable to the knockout mutations available for the yeast genome.
Harald von Melchner (University of Frankfurt Medical School) discussed progress of the German Gene Trap Consortium in executing similar large-scale mutagenesis of ES cells. Integration sites have been identified in over 7000 clones and include F2500 known genes. Over 70 germ line chimeras have been generated with over 60 % showing a phenotype. By using several genetrap vectors it appears that most genes can be targeted. Data is being deposited in a public database. This and the related efforts discussed above are moving forward at a very impressive rate towards saturation mutagenesis of the mouse genome with its consequent enlightenment at least for the earliest essential functions of most mouse genes.
Hrabe de Angelis (GSF Center for Environment and Health, Neuherberg) discussed a massive effort to identify interesting dominant and recessive mouse mutants generated by ENU mutagenesis. Currently, 405 confirmed lines have been developed, of which 39 are recessive mutations and 12 show behavioural phenotypes. This group has focussed analysis in part on studies of the notch/jagged signalling system in mice.
Recent findings include the knockout of a novel Delta1 gene allele and its effects on development of the endocrine pancreas as well as a role of the Notch system for inner ear development.
Adam Amsterdam (Massachusetts Institute of Technology, Cambridge, MA) described work from Nancy Hopkins group on large-scale mutagenesis in zebrafish. Their protocol uses mouse retroviral vectors as insertional mutagens and results in founder fish with multiple insertion sites. Several subsequent crosses are required to generate homozygous mutants. To date, 550 mutations have been bred to homozygosity and corresponding insertion sites have been cloned for 410 of these. This has identified 350 candidate genes, estimated to be 15-20 % of all genes that can be mutated to give a visible phenotype during the first five days of zebrafish life.
Complete SNP analysis for individuals would cause a combinatorial explosion in data (for example, all SNPs from just 1000 individuals would produce 20 billion possible phenotypes). Therefore, Sequenom (San Diego, California) is concentrating on haplotypes rather than individual SNPs and using DNA pooling to reduce the number of assays required. Michael Shi described how SNPs were detected by primer extension followed by MALDI TOF analysis. The integration of areas under peaks allows for a quantitative measure of the proportions of alleles in pooled samples. Common variants may be associated with diseases like diabetes, Alzheimer, HIV resistance, or cardiovascular diseases.
Sherman Weissman reviewed progress in the development of methods using DNA glycosidases to recover most or all mismatch-containing fragments from a pool of DNA duplexes. He further reviewed the Yale Center for Evolutionary and Genomic Studies preliminary applications of genomic tiling arrays to detection of these mismatch-containing fragments and potentially to other issues in mammalian genomics, such as global detection of transcription factors binding sites (ChipChip) experiments.
Protein analysis
Thomas Joos (NMI-Natural and Medical Sciences Institute, Tübingen) reviewed the principles of protein microarray technology and discussed applications including the parallel detection of antibodies directed against a number of potential autoantigens, for detection and monitoring the progress of autoimmune disorders in man. This type of array is only in the initial stages of development and application for biomedical purposes but offers similar promise to that obtained with cDNA microarrays.
Michael Snyder (Yale University) discussed his elegant work preparing and analysing arrays containing almost all proteins encoded by S. cerevisiae. These arrays have permitted detection of new activities including a number of tyrosine kinases. Other novel assays include detection of proteins binding to specific phosphorylated forms of inositol and direct detection of protein-protein interactions. Because the mammalian genome encodes fewer than ten fold more proteins than does yeast, these results offer hope that in the future extensive or nearly complete arrays of mammalian proteins might become available.
Jeremy Simpson (European Molecular Biology Laboratory, Heidelberg, Germany) discussed use of VERO cells, very large fibroblasts from monkeys, for visualization of protein localizations in intracellular structures. Of 1000 cDNAs targeted for analysis, 1270 have been successfully localized to one or more of 12 compartments of the cell, with a further F70 failing to localize due to interference from the green fluorescent protein used as a tag. This system also allows direct monitoring of protein transport through use of a temperature-sensitive mutant of the VSV-G protein, which is blocked in the endoplasmic reticulum at 38°C. Lowering of the temperature to 32°C releases the ER block, and proteins that affect the VSV-G protein transport can be determined by knockout studies.
Olof Emanuelsson (Stockholm Bioinformatics Center, Stockholm, Sweden) presented a study aiming at the in silico detection of proteins located in peroxisomes. All peroxisomal proteins containing the Peroxisomal Targeting Signal (PTS1) sequence (a total of 152) were collected from Swissprot, from which a total of 35 different PTS motifs were defined. Nonperoxisomal proteins containing the PTS1 signal were also collected as a negative control set. In this algorithm, the nine amino acids immediately N-terminal to the PST1 were analyzed by a combination of neural networks and support vector machines, and the motif accepted only if confirmed by one of the 35 known motifs. Further filtering by other predictors (like TargetP) to remove other subcellular compartment specific proteins (e.g. transmembrane proteins) resulted in prediction of only 60 peroxisomal proteins in eight higher eukaryotic genomes, with 80-90 % of all matching proteins correctly predicted as peroxisomal proteins.
Mark Gerstein (Yale University) focused on computational aspects of proteomics, in particular, on surveying the dead-protein-fossil pseudogenes in a number of large eukaryotic genomes. He identified pseudogenes in yeast, worm, fly and human, finding thousands of new ones. Some of the interesting findings were: (i) The population of pseudogenes is not uniform amongst protein families and tends to favour environmental response genes. (ii) There is a large number of processed pseudogenes in the human genome mostly stemming from ribosomal proteins. (iii) The fly genome has a very small number of pseudogenes, especially compared to its cousin the worm. However, this can be explained through a process of genome decay and one can find numerous broken up pseudo-motifs in this genome.
Large scale cDNA analysis
Ruth Wellenreuther from the German Cancer Center (DKFZ) in Heidelberg, Germany, presented the progress of the German cDNA consortium. They focused on size-selected RNAs for amplification and cDNA cloning to avoid length bias. As of October 2002 there were 160,105 clones available, representing 6627 different genes, all of which are being evaluated in a series of experimental as well as in silico assays. Also included are functional protein assays based on protein chips and antibody arrays. The database is called LIFEdb and is accessible at www.dkfz-heidelberg.de/abt0840/gfp.
Takashi Gojobori (National Institute of Genetics, Japan) described his research on the evolution of the central nervous system. He and his group have sequenced many expressed sequence tags (ESTs) from the brain of a primitive animal, the planarian (platyhelminth), and have conducted microarray analyses. From this work they have identified and characterized genes such as nou-darake (ndk) that play important roles in brain development.
Osamu Ohara (Kazusa DNA Research Institute, Riken, Japan) reported that a total of 12000 KIAA cDNAs, representing large cDNAs, and encoding large (1 100 kDa) proteins expressed in brain, have been sequenced. Because this is predicted to represent close to a complete set of such genes, efforts are now being directed towards isolation and sequencing of orthologous mouse cDNAs, preparation of antibodies to mouse proteins, and analysis by yeast two-hybrid screening.
Thomas Gingeras (Affymetrix, Santa Clara, USA) showed data from non-repetitive sequence, genomic nucleotide arrays of human chromosomes 21 and 22, screened with cytoplasmic cDNA from 11 cell lines (10 of which were cancer cell lines). Surprisingly, 24 % and 65 % of positive probes were found in intron and intergenic regions (in at least five of the 11 cell lines tested), respectively, with a subset verified by RT PCR or Northern hybridization. A number of regulatory factor binding sites (for c-myc, SP1 and p53) were defined by chromatin immunoprecipitation, within upstream regions of the putative new transcripts, as well as at the 5) ends of known genes. These data suggest much higher transcriptional activity, of unknown function, than anticipated.
Martin Ringwald (The Jackson Laboratory, Bar Harbor, Maine) reported on the ongoing development of the Mouse Expression Database (GXD). This database has now completed literature analysis for gene expression during the mouse embryonal development from the year of 1993 to present. Ringwald also proposed to use orthogonal vocabularies to describe phenomena, such as functional terms (e.g. induce or cause) together with anatomical terms (e.g. bones or liver) and medical terms (e.g. cancer or diabetes). This results in an almost natural language description that abides strictly by the rules of controlled vocabularies and is thus computer processible.
cDNA arrays
Dr. Yoav Arava (Stanford University) studied translational efficiency in S. cerevisiae, by experiments measuring the distribution of mRNAs associated with polysomes. This was coupled with a method for specific cleavage in the central portion of an mRNA. Overall conclusions were that elongation is processive and that termination is not a slow step in protein generation, but that initiation is rate limiting for most mRNAs and, in general, longer mRNAs, in particular those with long 3)UTRs, are translated less efficiently because of slower initiation rates.
Proteins encoding RNA Recognition Motifs (RRMs) represent the seventh most abundant protein family and are likely to play diverse roles in regulation of many features of RNA processing and metabolism. Scott Tenenbaum (Duke University Medical School) reported on efforts to correlate individual RNA binding proteins with their target mRNAs. ProteinmRNA complexes were precipitated using an antibody to the specific RNA binding protein (e.g. PABP, FMRP), and associated RNAs are then labelled and used to screen a Clontech cDNA array. Unique subsets of RNAs have been identified, allowing further analysis of recognition sequences.
Aravind Raghavan (University of Minnesota) discussed analysis of mRNA decay rates, using actinomycin D to prevent new mRNA synthesis, in T cells before and after activation of the cells. He observed many short lived transcripts and, importantly, many transcripts that were either stabilized or destabilized by cell activation. Many of the transcripts regulated at the level of mRNA stability contained no previously characterised stability determinants, emphasizing how much remains to be learned in this field.
Dr. Michael Liebler (Raytest GmbH, Straubenhardt, Germany) presented data on the variability of results in array experiments caused by different software evaluation strategies for spot detection and background subtraction. Comparison of three spot detection methods (variable spot area with autocontouring of spot shape, variable spot diameter and background subtraction, and constant spot diameter and background subtraction) showed no significant differences for spots with high signal intensities. However, for low intensity signals, the spot detection with variable spot area with autocontouring of the spot shape, as well as the variable spot diameter demonstrated a clear tendency to underestimate or ignore spot data.
Michael Bittner (National Institute for Genome Research, Bethesda, MD) described insightful interpretation of cDNA array data for the identification of genes relevant to melanoma. Mutations causing coat color and eye defects in mouse map near the Rab38 gene, implicated as a candidate gene for human melanoma.
Expression networks
Thomas Werner (Genomatix Software GmbH, Munich, Germany) presented studies with the PAX8 gene as an example of in silico determination of potential targets for a transcription factor (TF). For most promoters, multiple TF binding sites are required and transcriptional response is only elicited by two or more factors binding simultaneously. For PAX8, this computational approach helped to reduce the number of candidate target genes F100-fold, leading to the identification of a functional PAX8 network in signal transduction.
Sorin Istrail (Celera Genomics) described the Davidson model of transcription regulation developed in sea urchin, and focussing on the endo16 gene and its associated network of interactions. Transcription factor binding sites and promoter modules were defined experimentally through exhaustive mutational analysis. Mathematical models of the network and algorithms related to it were discussed as an illustration of techniques that may be useful in analysis of diverse regulatory networks in this and other organisms.
Katheleen Gardiner (Eleanor Roosevelt Institute, Denver, CO) described how perturbations of protein networks and interactions, rather than single chromosome 21-gene overexpression, must be the basis of the mental retardation phenotype of Down syndrome (DS). Among examples discussed were seven genes mapping to chromosome 21 that directly function in pre-mRNA splicing or the spliceosome, suggesting a global disruption of alternative splicing may be contributing to the DS phenotype. A second example involves seven genes that interact with components of the MAP Kinase pathway. Preliminary data suggest that the MAPK pathway, in particular, levels of phosphorylation of ERK1/2 and Akt1/2, are altered in brains of the mouse model of DS.
Alvis Brazma (European Bioinformatics Institute, Hinxton/ Cambridge, UK) described an approach to deduce gene networks from microarray data. To construct gene disruption networks, the micro array data are first discretized into +, -and 0, by using suitable filters. The relative distribution of incoming and outgoing edges across a complete set of genes allows construction of scale-free networks. Genes associated with a high degree of outgoing edges are regulatory genes, while high degrees of ingoing edges usually are metabolic genes. Removing one node at a time creates independent sets of genes connected only to each other, within sets that are called network modules.
Sudhir Kumar (Arizona State University) reported on a new computational approach for comparing gene expression patterns from early developmental stages of Drosophila melanogaster. A database of expression patterns was created through digitization of available published images (thousands) and computational tools were developed to search the database using query images, analogous to the way BLAST finds similar sequences. Such methodology could be extended to other organisms and should accelerate discovery of developmental networks.
Jürgen Bode (German Biotechnology Institute, Braunschweig, Germany) reported on the use of a biomathematical method called Stress Induced Destabilization of Doublestrands (SIDD) to successfully predict functional Scaffold or Matrix Attachment Regions (SMARs) in the Interferon type I gene cluster on the short arm of chromosome 9. SMARs predicted near the 5) ends of genes could be confirmed by single-strand analysis, while those SIDD predictions located within the coding region showed no SMAR activity. DNA methylation appeared not to be involved while secondary structure potential is an important SMAR feature. Possibly related observations were described by Alla Rynditch (Institute of Molecular Biology and Genetics, Kiev, Ukraine), who has shown that the alpha-globin genes in chicken leukemia cells are transcribed and stabilized as a single "full domain transcript" spanning 30 kb and containing all three alpha-type globin genes. This large transcript exists in spite of the presence of internal CpG islands and SMARs. Interestingly, it is found as a component of the nuclear matrix and turns over slowly, possibly suggesting a novel mechanism of post-transcriptionl regulation because these globin genes do not appear as proteins in these cells.
Alternative splicing and pre-mRNA processing
Lynne Maquat (University of Rochester Medical Center, Rochester, NY) discussed aspects of Nonsense Mediated Decay and its relationship to alternative splicing events that introduce premature stop codons. Stefan Stamm (Institute of Biochemistry, Erlangen, Germany) discussed the role of phosphorylation in alternative splicing. Specific examples include the CDC2-like kinases, CLK1-4, that phosphorylate serine-arginine-rich proteins, that in turn regulate alternative splicing, abl-mediated phosphorylation of SLM2 which results in exon skipping in the tau protein mRNA, and insulin treatment altering phosphorylation of SRp40 which in turn alters alternative splicing of PKG.
Winston Hide (South African National Bioinformatics Institute, Cape Town, South Africa) analyzed RefSeq and dbEST sequences to describe alternative splicing events caused by exon skipping. Because 90 % of such events occur in coding regions, they affect protein coding, with F50 % resulting in reading frame truncation. Currently, the observed frequency of exon skipping in mouse transcripts is lower than in human, which may simply be due to the lower quality of the mouse genomic assembly. To correlate exon skipping events with disease (e.g. cancer), Hide proposed a controlled vocabulary to describe ontologies for cell type, developmental stage and pathology, thus permitting their linkage to transcript accession numbers.
Kirk Jensen (Rockefeller University, New York) also reported on efforts to identify targets of the RNA binding proteins, NOVA and Hu, relevant to nervous system development. A novel protocol, CLIP, has been developed in which RNAprotein complexes are photo-crosslinked in situ directly in neurons. The RNA is then "clipped" to the 36-60 nucleotides protected by the protein, followed by immune precipitation with appropriate antibody, and purification and cloning of the RNAs. Analysis of 130 RNAs has shown the following distribution: 75 % are located within introns, 20 % are adjacent to alternatively spliced exons, 20 % are within 3)UTRs and 2 % are located within coding exons. These data suggest potentially diverse functions relevant to processing and stability.
The ADAR1 protein functions in the deamination of specific adenosine residues in specific pre-mRNAs. Although wellcharacterized substrates include serotonin and glutamate receptors, Jing-Hua Yang (Yale University) has shown that ADAR1activity is broader than that. ADAR1 activity, as monitored by inosine (the direct product of deamination) production, is increased in spleen, thymus and lung during inflammation. RNA and protein isoform patterns are also altered, most often affecting the nuclear localization signal, the Z-DNA binding domain or one of the RNA binding domains of the protein. These novel isoforms appear to be responsible for a shift in localization from the nucleus to the nucleolus and the cytoplasm, suggesting possible novel functions for ADAR1.
Gene organizational analyses
Lee Rowen (Institute for Systems Biology, Seattle) described the identification and organization of 211 human genes each spanning 1500 kb in genomic DNA, and thus together accounting for F5 % of the human genome. Such genes tend to be located within AT-rich regions, exhibit highly complex alternative splicing, although mature mRNAs average only 2.9 kb, play critical roles in development and physiology of the central nervous system, and are frequently located at sites of chromosomal instability. Lastly, the large sizes appear to be conserved in mouse.
Yoram Groner (The Weizmann Institute, Rehovot, Israel) discussed the family of three mammalian Runx transcription factors. Runx1 (nee AML1) is often disrupted by chromosomal translocations in acute leukemia and is essential for definitive hematopoiesis. The gene is transcribed from either of two widely separated promoters, one of which produces a 5) untranslated region of over 400 bases and includes an IRES. Runx3 is also transcribed from two alternative promoters. However, unlike Runx1, knockout of Runx3 leads to a specific neurological deficit (severe ataxia) as a consequence of apoptosis of a subset of dorsal root ganglion neurons.
Tom Blumenthal (University of Colorado Health Sciences Center, Denver, CO) described the identification and characterization of operons in C. elegans, where a total of 2327 genes are found to be transcribed as 898 operons. Frequently included in operons are mitochondrial genes, and genes with roles in transcription and translation; excluded from operons are transcription factors and collagen genes. Interesting additional features of operons are that they are not defined by their promoters (switching an operon promoter for a non-operon promoter still results in transcription as an operon), component genes do necessarily appear in equal levels, and component genes are not necessarily obviously functionally related. Lastly, where operon components are functionally related, they may provide a useful tool for analysis of orthologous human disease related genes.
Evolutionary and computational approaches
Xun Gu (Iowa State University) discussed his recent work testing two theories for the evolution of the vertebrate genome. One model suggests that there were two complete genome duplications (polyploidizations) in the history of vertebrates whereas another model postulates continuous small-scale duplications. His dating of 1,739 gene duplication events provided support for inclusion of both models, involving at least one complete genome duplication followed by a wave of smaller-scale duplications.
Blair Hedges (Pennsylvania State University) discussed some recent bioinformatic studies in his laboratory concerning the evolution of complex multicellular life. The times of divergence between selected protists, plants, animals, and fungi were estimated using sequences from 50-150 genes each. The results show that organismal complexity increased much earlier (1.5 billion years ago) than previously believed and about a billion years before the Cambrian explosion of animals.
Naruya Saitou (National Institute of Genetics, Japan) reported on work from his group, with the goal of identifying genetic changes responsible for morphological traits unique to humans. As a pilot project, they targeted the HOXA gene cluster in humans and apes and sequenced 21 kilobases (100 kilobases for gorillas and chimpanzees), including the HOXA4, HOXA5, HOXA6, and HOXA7 genes. With these data they were able to identify several short DNA regions of potential value in addressing these evolutionary questions. 
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